ICU Medical Inc (ICUI)

Currency in USD
178.85
+6.74(+3.92%)
Closed·
178.850.00(0.00%)
·
ICUI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
172.55181.29
52 wk Range
113.37192.85
Key Statistics
Prev. Close
178.85
Open
173.9
Day's Range
172.55-181.29
52 wk Range
113.37-192.85
Volume
344.71K
Average Volume (3m)
253.99K
1-Year Change
28.4565%
Book Value / Share
87.63
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ICUI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
194.25
Upside
+8.61%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

ICU Medical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 194.25
(+8.61% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Buy200.00+11.83%195.00MaintainNov 09, 2026
KeyBanc
Buy189.00+5.68%187.00MaintainNov 09, 2026
Piper Sandler
Buy200.00+11.83%195.00MaintainNov 06, 2026
KeyBanc
Buy189.00+5.68%187.00MaintainNov 06, 2026
Piper Sandler
Buy195.00+9.03%163.00MaintainAug 07, 2026

ICU Medical Inc Earnings Call Summary for Q2/2026

  • ICU Medical Q2 adjusted EPS of $2.37 beat estimates by 24%; revenue of $548M topped forecasts, rising 6% organically year-over-year.
  • Company raised full-year adjusted EPS guidance to $8.60-$9.00 from $7.75-$8.45; EBITDA outlook increased to $415M-$435M from $400M-$430M.
  • Infusion systems posted record quarter with 13% reported growth; consumables grew 6% despite tariff headwinds of $30M-$40M annually.
  • Net leverage fell to 2.3x after $50M debt repayment; company targets 2.0x by year-end with $150M free cash flow expected for 2026.
  • Shares rose 3.7% after-hours to $172.57, nearing 52-week high; FDA submission for Medfusion 5000 syringe pump expected in 2026.
Last Updated: 2026-08-06, 05:26 p/m
Read Full Transcript

Earnings

Latest Release
Nov 05, 2026
EPS / Forecast
2.44 / 2.08
Revenue / Forecast
560.4M / 552.13M
EPS Revisions
Last 90 days

ICUI Income Statement

Compare ICUI to Peers and Sector

Metrics to compare
ICUI
Peers
Sector
Relationship
P/E Ratio
74.1x22.8x−0.2x
PEG Ratio
0.090.650.00
Price/Book
2.0x2.5x2.6x
Price / LTM Sales
2.0x2.5x2.8x
Upside (Analyst Target)
8.6%0.0%60.9%
Fair Value Upside
Unlock16.0%9.5%Unlock

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company’s customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
14.93M59.71%2.57B
Other Institutional Investors
11.55M40.29%1.99B
Public Companies & Retail Investors
0.000.00%0.00
Total
26.48M100.00%4.56B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.15.01%3,753,409645,999
Janus Henderson Group Ltd.11.12%2,781,620478,745

People Also Watch

51.94
CNMD
+0.85%
671.97
CVCO
+5.23%
63.32
BHE
+4.83%
205.64
PLXS
+7.01%
32.47
NTCT
+3.05%

FAQ

What Is the ICU Medical (ICUI) Stock Price Today?

The ICU Medical stock price today is 178.85 USD.

What Stock Exchange Does ICU Medical Trade On?

ICU Medical is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for ICU Medical?

The stock symbol for ICU Medical is "ICUI."

What Is the ICU Medical Market Cap?

As of today, ICU Medical market cap is 4.47B USD.

What Is ICU Medical's Earnings Per Share (TTM)?

The ICU Medical EPS (TTM) is 2.43.

When Is the Next ICU Medical Earnings Date?

ICU Medical will release its next earnings report on Mar 03, 2027.

From a Technical Analysis Perspective, Is ICUI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has ICU Medical Stock Split?

ICU Medical has split 2 times.

How Many Employees Does ICU Medical Have?

ICU Medical has 13000 employees.

What is the current trading status of ICU Medical (ICUI)?

As of Nov 10, 2026, ICU Medical (ICUI) is trading at a price of 178.85 USD, with a previous close of 178.85 USD. The stock has fluctuated within a day range of 172.55 USD to 181.29 USD, while its 52-week range spans from 113.37 USD to 192.85 USD.

What Is ICU Medical (ICUI) Price Target According to Analysts?

The average 12-month price target for ICU Medical is 194.25 USD, with a high estimate of 210 USD and a low estimate of 178 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +8.61% Upside potential.

What Is the ICUI Premarket Price?

ICUI's last pre-market stock price is 174.02 USD. The pre-market share volume is 590.00, and the stock has decreased by 1.91, or 1.11%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.